Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Beclomethasone Dipropionate · Beclovent, Vancenase

Small molecule · Agonist of glucocorticoid receptor (NR3C1) · developed by Schering

Approved FDA, May 1976
1 Registered trials

What is Beclomethasone Dipropionate?

Beclomethasone dipropionate is the dipropionate ester of a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. After entering the cell, it binds and activates nuclear glucocorticoid receptors, altering gene expression and inhibiting proinflammatory cytokine production. It is studied in asthma.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Beclovent, Vancenase, Vanceril, Reference Product
Drug type
Small molecule
Targets
glucocorticoid receptor (NR3C1)
Mechanism
Agonist of glucocorticoid receptor (NR3C1)
Pathways
gene expression regulation, proinflammatory cytokine production inhibition
Therapy area
Respiratory
Developer
Schering
In trials of
AMRX
FDA status
Approved as Beclovent, Vancenase, Vanceril (May 12, 1976), NDA017573

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT03562949 Phase 3 Asthma Terminated AMRX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Asthma

Other drugs acting on NR3C1

Budesonide FDA approved IDP-118 FDA approved Infacort FDA approved Methylprednisolone FDA approved Mifepristone FDA approved Mometasone FDA approved Mometasone Furoate FDA approved Relacorilant FDA approved Chronocort Phase 3 Exicorilant Phase 1/2 Miricorilant Phase 2 ORIC-101 Phase 1

Sources

Updated Oct 11, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.